Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK(1)) receptor antagonists

Chemotherapy-induced nausea (CIN) has a significant negative impact on the quality of life of cancer patients. The use of 5-hydroxytryptamine-3 (5-HT(3)) receptor antagonists (RAs) has reduced the risk of vomiting, but (except for palonosetron) their effect on nausea, especially delayed nausea, is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Bošnjak, Snežana M., Gralla, Richard J., Schwartzberg, Lee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378744/
https://www.ncbi.nlm.nih.gov/pubmed/28108820
http://dx.doi.org/10.1007/s00520-017-3585-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5378744/
https://www.ncbi.nlm.nih.gov/pubmed/28108820
http://dx.doi.org/10.1007/s00520-017-3585-z

Ejemplares similares